Efficacy and safety of everolimus plus low-dose calcineurin inhibitor vs. mycophenolate mofetil plus standard-dose calcineurin inhibitor in renal transplant recipients: A systematic review and meta-analysis  .

CONCLUSION: EVR plus low-dose CNI regimen was similar in efficacy and safety to MMF plus standard-dose CNI regimen after KT. However, this should be confirmed by further studies. . PMID: 29292693 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29292693?dopt=Abstract

Source: Clinical Nephrology - January 2, 2018 Category: Urology & Nephrology Authors: He L, Deng J, Yang B, Jiang W Tags: Clin Nephrol Source Type: research

Efficacy and safety of everolimus plus low-dose calcineurin inhibitor vs. mycophenolate mofetil plus standard-dose calcineurin inhibitor in renal transplant recipients: A systematic review and meta-analysis .

Efficacy and safety of everolimus plus low-dose calcineurin inhibitor vs. mycophenolate mofetil plus standard-dose calcineurin inhibitor in renal transplant recipients: A systematic review and meta-analysis  .